المؤلفون: Alhazzani K, Mohammed H, Algahtani MM, Aljerian K, Alhoshani A, As Sobeai HM, Ahamad SR, Alotaibi MR, Alhamed AS, Alasmari F, Alqinyah M, Alhamami HN, Alanazi AZ

المصدر: Drug Design, Development and Therapy, Vol Volume 18, Pp 5641-5654 (2024)

مصطلحات موضوعية: cardiac toxicity, dasatinib, valsartan, metabolomics, histopathology., Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/integrating-metabolomics-histopathology-and-cardiac-marker-analysis-to-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881

URL الوصول: https://doaj.org/article/7577afddcef14c00aff5a7be49986161